Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors.

Cancers (Basel) · 2021 · PMC8235746 · PMID 34205778

Europe PMC DOI

hedged sentence

0.0173

closest p · 0.3× alpha

0.0173

boldest claim

The sentences

a positive trendp = 0.01727actually significant

Not surprisingly, in the control group, there was a positive trend between the number of Ki67-positive cells and absolute tumor volume in males and females ( p = 0.01727).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.